Kinfo
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

FLGTNASDAQHealthcare·US · USD
$21.72
+0.90 (+4.32%)
Prices as of October 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap597.63M USD
Enterprise value312.93M USD
Trailing P/E-11.03
Forward P/E-15.55
PEG ratio-0.16
Price / sales1.82
Price / book0.59
Profitability
Gross margin30.07%
Operating margin-39.35%
Profit margin-26.05%
Return on assets-6.30%
Return on equity-8.11%
Income (TTM)
Revenue323.93M USD
Gross profit115.26M USD
EBITDA-89.46M USD
Net income-84.38M USD
Diluted EPS-$2.82
Rev. growth (YoY)4.40%
Balance sheet
Total cash257.03M USD
Total debt9.60M USD
Debt / equity0.96
Current ratio6.34
Book value / share$36.40
Cash flow (TTM)
Operating cash flow-83.70M USD
Levered free cash flow-90.90M USD
Shares & price
Shares outstanding27.52M
Float16.69M
Held by institutions58.40%
Beta0.93
50-day MA$20.13
200-day MA$19.88
52-week high$31.04
52-week low$13.46
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-07-30-0.44-0.58−31.82%2026-05-01-0.35-0.36−2.86%2026-02-270.030.16+433.33%2026-02-100.961.00+4.17%2026-01-231.611.87+16.15%
About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. is a healthcare diagnostics company that provides molecular testing, genetic testing, and anatomic pathology services to physicians, hospitals, and medical institutions. Its offerings cover a broad range of clinical areas, including hereditary cancer, reproductive health, oncology, gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology. The company also provides sequencing-based solutions and laboratory services designed to support clinically actionable medical decision-making. In addition to its diagnostic business, Fulgent Genetics, Inc. operates therapeutic development activities focused on cancer-related drug candidates. Headquartered in El Monte, California, the company serves customers in the United States and internationally and plays a role in combining laboratory testing, bioinformatics, and specialized pathology services within the broader precision medicine market.

Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Ming Hsieh
Employees
1,315
Headquarters
El Monte, CA, United States

Frequently asked questions about Fulgent Genetics, Inc.